$SEPN
Septerna, Inc.

2024 Q4 Form 10-Q Financial Statement

#000095017024129274 Filed on November 20, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2024 Q2
Revenue $176.0K $690.00
YoY Change 433.33%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $6.050K
YoY Change 57.96%
% of Gross Profit
Research & Development $17.83M $28.19K
YoY Change 92.13% 72.21%
% of Gross Profit
Depreciation & Amortization $400.0K $650.00
YoY Change 100.0% 75.68%
% of Gross Profit
Operating Expenses $22.73M $34.24K
YoY Change 88.24% 69.5%
Operating Profit -$22.55M
YoY Change 87.29%
Interest Expense $2.810K
YoY Change 538.64%
% of Operating Profit
Other Income/Expense, Net $1.891M -$60.00
YoY Change 72.69%
Pretax Income -$20.66M -$30.81K
YoY Change 88.75% 55.84%
Income Tax -$136.0K -$200.00
% Of Pretax Income
Net Earnings -$20.52M -$16.51M
YoY Change 87.51% 55.78%
Net Earnings / Revenue -11660.8% -2392753.62%
Basic Earnings Per Share -$8.40
Diluted Earnings Per Share -$8.40 $0.00
COMMON SHARES
Basic Shares Outstanding 44.40M 2.444M
Diluted Shares Outstanding 2.444M

Balance Sheet

Concept 2024 Q4 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $148.8K
YoY Change
Cash & Equivalents $88.24M $131.2K
Short-Term Investments $17.67K
Other Short-Term Assets $241.0K $1.860K
YoY Change
Inventory
Prepaid Expenses $1.152M
Receivables $210.0K $200.00
Other Receivables $330.00
Total Short-Term Assets $133.4M $151.2K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $5.412M $17.15K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $6.850K
YoY Change
Other Assets $3.479M $500.00
YoY Change
Total Long-Term Assets $40.87M $24.51K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $133.4M $151.2K
Total Long-Term Assets $40.87M $24.51K
Total Assets $174.3M $175.7K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.128M $2.320K
YoY Change
Accrued Expenses $5.987M $5.190K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $13.23M $7.760K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $191.0K $12.48K
YoY Change
Total Long-Term Liabilities $191.0K $12.48K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $13.23M $7.760K
Total Long-Term Liabilities $191.0K $12.48K
Total Liabilities $37.53M $20.24K
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$97.70M
YoY Change
Common Stock $10.12M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$87.41M -$67.76M
YoY Change
Total Liabilities & Shareholders Equity $174.3M $176.6K
YoY Change

Cashflow Statement

Concept 2024 Q4 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$20.52M -$16.51M
YoY Change 87.51% 55.78%
Depreciation, Depletion And Amortization $400.0K $650.00
YoY Change 100.0% 75.68%
Cash From Operating Activities -$29.70K
YoY Change 48.57%
INVESTING ACTIVITIES
Capital Expenditures $910.00
YoY Change -26.61%
Acquisitions
YoY Change
Other Investing Activities -$1.650K
YoY Change
Cash From Investing Activities -$2.570K
YoY Change 107.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 74.95K
YoY Change 4.88%
NET CHANGE
Cash From Operating Activities -29.70K
Cash From Investing Activities -2.570K
Cash From Financing Activities 74.95K
Net Change In Cash 42.68K
YoY Change -15.03%
FREE CASH FLOW
Cash From Operating Activities -$29.70K
Capital Expenditures $910.00
Free Cash Flow -$30.61K
YoY Change 44.18%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001984086
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-42382
dei Entity Registrant Name
EntityRegistrantName
Septerna, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-3891440
dei Entity Address Address Line1
EntityAddressAddressLine1
250 East Grand Avenue
dei Entity Address City Or Town
EntityAddressCityOrTown
South San Francisco
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94080
dei City Area Code
CityAreaCode
650
dei Local Phone Number
LocalPhoneNumber
338-3533
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
SEPN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
44402742
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
88242000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
88483000
CY2024Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
42291000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
210000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
151000
CY2023Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
22625000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2668000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1419000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
133411000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
112678000
CY2024Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
6979000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5412000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4665000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
24095000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12522000
CY2024Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
905000
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
905000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3479000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
97000
CY2024Q3 us-gaap Assets
Assets
174281000
CY2023Q4 us-gaap Assets
Assets
130867000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
6128000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2637000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5987000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4277000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1116000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
13231000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6914000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
24110000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12566000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
191000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
546000
CY2024Q3 us-gaap Liabilities
Liabilities
37532000
CY2023Q4 us-gaap Liabilities
Liabilities
20026000
CY2024Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
224157000
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
149215000
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
3000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
3000
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
10119000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
8199000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
176000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-97706000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-46576000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-87408000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-38374000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
174281000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
130867000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
176000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
863000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17832000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9281000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
46020000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
25653000
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4894000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2792000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10948000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6622000
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
22726000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
12073000
us-gaap Operating Expenses
OperatingExpenses
56968000
us-gaap Operating Expenses
OperatingExpenses
32275000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-22550000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-12040000
us-gaap Operating Income Loss
OperatingIncomeLoss
-56105000
us-gaap Operating Income Loss
OperatingIncomeLoss
-32242000
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1900000
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1096000
us-gaap Investment Income Interest
InvestmentIncomeInterest
4709000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1531000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3000
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1891000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1095000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4637000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1528000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-20659000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10945000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-51468000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30714000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-136000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-338000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-20523000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-10945000
us-gaap Net Income Loss
NetIncomeLoss
-51130000
us-gaap Net Income Loss
NetIncomeLoss
-30714000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-8.4
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-8.4
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.45
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.45
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-21.87
us-gaap Operating Expenses
OperatingExpenses
32275000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-22550000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-12040000
us-gaap Operating Income Loss
OperatingIncomeLoss
-56105000
us-gaap Operating Income Loss
OperatingIncomeLoss
-32242000
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1900000
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1096000
us-gaap Investment Income Interest
InvestmentIncomeInterest
4709000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1531000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-72000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3000
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1891000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1095000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4637000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1528000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-20659000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10945000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-51468000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30714000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-136000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-338000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-20523000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-10945000
us-gaap Net Income Loss
NetIncomeLoss
-51130000
us-gaap Net Income Loss
NetIncomeLoss
-30714000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-8.4
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-8.4
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.45
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.45
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-21.87
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-21.87
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-16.49
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-16.49
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2443678
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2443678
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2007620
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2007620
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2337891
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2337891
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1862036
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1862036
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-20523000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-10945000
us-gaap Net Income Loss
NetIncomeLoss
-51130000
us-gaap Net Income Loss
NetIncomeLoss
-30714000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-21.87
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-16.49
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-16.49
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2443678
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2443678
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2007620
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2007620
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2337891
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2337891
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1862036
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1862036
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-20523000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-10945000
us-gaap Net Income Loss
NetIncomeLoss
-51130000
us-gaap Net Income Loss
NetIncomeLoss
-30714000
CY2024Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
184000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
176000
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
184000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
176000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20339000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10945000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-50954000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-30714000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-38374000
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000
CY2024Q1 sepn Stock Issued During Period Values Restricted Stock Award Vested
StockIssuedDuringPeriodValuesRestrictedStockAwardVested
6000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
577000
CY2024Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-7000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-14097000
CY2024Q2 sepn Stock Issued During Period Values Restricted Stock Award Vested
StockIssuedDuringPeriodValuesRestrictedStockAwardVested
4000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
628000
CY2024Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-1000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-16510000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-67763000
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5000
CY2024Q3 sepn Stock Issued During Period Values Restricted Stock Award Vested
StockIssuedDuringPeriodValuesRestrictedStockAwardVested
6000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
683000
CY2024Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
184000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-20523000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-87408000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-44201000
CY2023Q1 sepn Stock Issued During Period Values Restricted Stock Award Vested
StockIssuedDuringPeriodValuesRestrictedStockAwardVested
6000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
343000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-9171000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-53023000
CY2023Q2 sepn Stock Issued During Period Values Restricted Stock Award Vested
StockIssuedDuringPeriodValuesRestrictedStockAwardVested
9000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
355000
CY2024Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
184000
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
184000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
176000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20339000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10945000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-50954000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-30714000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-38374000
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000
CY2024Q1 sepn Stock Issued During Period Values Restricted Stock Award Vested
StockIssuedDuringPeriodValuesRestrictedStockAwardVested
6000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
577000
CY2024Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-7000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-14097000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-51894000
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10000
CY2024Q2 sepn Stock Issued During Period Values Restricted Stock Award Vested
StockIssuedDuringPeriodValuesRestrictedStockAwardVested
4000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
628000
CY2024Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-1000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-16510000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-67763000
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5000
CY2024Q3 sepn Stock Issued During Period Values Restricted Stock Award Vested
StockIssuedDuringPeriodValuesRestrictedStockAwardVested
6000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
683000
CY2024Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
184000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-20523000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-87408000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-44201000
CY2023Q1 sepn Stock Issued During Period Values Restricted Stock Award Vested
StockIssuedDuringPeriodValuesRestrictedStockAwardVested
6000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
343000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-9171000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-53023000
CY2023Q2 sepn Stock Issued During Period Values Restricted Stock Award Vested
StockIssuedDuringPeriodValuesRestrictedStockAwardVested
9000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
355000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-10598000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-63257000
CY2023Q3 sepn Stock Issued During Period Values Restricted Stock Award Vested
StockIssuedDuringPeriodValuesRestrictedStockAwardVested
6000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
347000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-10945000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-73849000
us-gaap Profit Loss
ProfitLoss
-51130000
us-gaap Profit Loss
ProfitLoss
-30714000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1013000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
605000
us-gaap Operating Lease Expense
OperatingLeaseExpense
890000
us-gaap Operating Lease Expense
OperatingLeaseExpense
515000
us-gaap Share Based Compensation
ShareBasedCompensation
1888000
us-gaap Share Based Compensation
ShareBasedCompensation
1045000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-10598000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-63257000
CY2023Q3 sepn Stock Issued During Period Values Restricted Stock Award Vested
StockIssuedDuringPeriodValuesRestrictedStockAwardVested
6000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
347000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-10945000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-73849000
us-gaap Profit Loss
ProfitLoss
-51130000
us-gaap Profit Loss
ProfitLoss
-30714000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1013000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
605000
us-gaap Operating Lease Expense
OperatingLeaseExpense
890000
us-gaap Operating Lease Expense
OperatingLeaseExpense
515000
us-gaap Share Based Compensation
ShareBasedCompensation
1888000
us-gaap Share Based Compensation
ShareBasedCompensation
1045000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
-601000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-338000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-52000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-5000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1249000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
34000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
60000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
33000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
173000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
215000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2419000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1131000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
579000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
559000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
198000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-528000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-46512000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-29926000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1491000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1639000
sepn Proceeds From Sale Of Non Financial Asset
ProceedsFromSaleOfNonFinancialAsset
22625000
sepn Proceeds From Sale Of Non Financial Asset
ProceedsFromSaleOfNonFinancialAsset
25000000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
65828000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
17335000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27359000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
23361000
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
74942000
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
74521000
sepn Repurchases Of Unvested Restricted Common Stock
RepurchasesOfUnvestedRestrictedCommonStock
1000
sepn Repurchases Of Unvested Restricted Common Stock
RepurchasesOfUnvestedRestrictedCommonStock
1000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
16000
sepn Payments Of Deferred Offering Costs
PaymentsOfDeferredOfferingCosts
1327000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
73630000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
74520000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
-601000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-338000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-52000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-5000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1249000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
34000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
60000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
33000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
173000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
215000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2419000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1131000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
579000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
559000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
198000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-528000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-46512000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-29926000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1491000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1639000
sepn Proceeds From Sale Of Non Financial Asset
ProceedsFromSaleOfNonFinancialAsset
22625000
sepn Proceeds From Sale Of Non Financial Asset
ProceedsFromSaleOfNonFinancialAsset
25000000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
65828000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
17335000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27359000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
23361000
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
74942000
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
74521000
sepn Repurchases Of Unvested Restricted Common Stock
RepurchasesOfUnvestedRestrictedCommonStock
1000
sepn Repurchases Of Unvested Restricted Common Stock
RepurchasesOfUnvestedRestrictedCommonStock
1000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
16000
sepn Payments Of Deferred Offering Costs
PaymentsOfDeferredOfferingCosts
1327000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
73630000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
74520000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-241000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
67955000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
31469000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
89147000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
99424000
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
88242000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
98519000
CY2024Q3 us-gaap Restricted Cash
RestrictedCash
905000
CY2023Q3 us-gaap Restricted Cash
RestrictedCash
905000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
89147000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
99424000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
232000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
12462000
sepn Unpaid Deferred Offering Cost Included In Accounts Payable And Accrued Expenses And Other Current Liabilities
UnpaidDeferredOfferingCostIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities
1882000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-241000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
67955000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
89388000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
31469000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
89147000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
99424000
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
88242000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
98519000
CY2024Q3 us-gaap Restricted Cash
RestrictedCash
905000
CY2023Q3 us-gaap Restricted Cash
RestrictedCash
905000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
89147000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
99424000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
232000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
12462000
sepn Unpaid Deferred Offering Cost Included In Accounts Payable And Accrued Expenses And Other Current Liabilities
UnpaidDeferredOfferingCostIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities
1882000
sepn Property And Equipment Included In Accounts Payable And Accrued Expenses And Other Current Liabilities
PropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities
321000
sepn Property And Equipment Included In Accounts Payable And Accrued Expenses And Other Current Liabilities
PropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities
355000
us-gaap Net Income Loss
NetIncomeLoss
-51100000
us-gaap Net Income Loss
NetIncomeLoss
-30700000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-97700000
CY2024Q3 sepn Cash Cash Equivalents Marketable Securities Current And Non Current
CashCashEquivalentsMarketableSecuritiesCurrentAndNonCurrent
137500000
sepn Property And Equipment Included In Accounts Payable And Accrued Expenses And Other Current Liabilities
PropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities
321000
sepn Property And Equipment Included In Accounts Payable And Accrued Expenses And Other Current Liabilities
PropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities
355000
us-gaap Net Income Loss
NetIncomeLoss
-51100000
us-gaap Net Income Loss
NetIncomeLoss
-30700000
CY2024Q3 sepn Cash Cash Equivalents Marketable Securities Current And Non Current
CashCashEquivalentsMarketableSecuritiesCurrentAndNonCurrent
137500000
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1152000
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
874000
CY2024Q3 sepn Prepaid Clinical Trial Costs Current
PrepaidClinicalTrialCostsCurrent
679000
CY2024Q3 sepn Prepaid Bonus Current
PrepaidBonusCurrent
241000
CY2023Q4 sepn Prepaid Bonus Current
PrepaidBonusCurrent
378000
CY2024Q3 sepn Prepaid Taxes Current
PrepaidTaxesCurrent
232000
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1152000
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
874000
CY2024Q3 sepn Prepaid Clinical Trial Costs Current
PrepaidClinicalTrialCostsCurrent
679000
CY2024Q3 sepn Prepaid Bonus Current
PrepaidBonusCurrent
241000
CY2023Q4 sepn Prepaid Bonus Current
PrepaidBonusCurrent
378000
CY2024Q3 sepn Prepaid Taxes Current
PrepaidTaxesCurrent
232000
CY2023Q4 sepn Prepaid Taxes Current
PrepaidTaxesCurrent
75000
CY2024Q3 us-gaap Interest Receivable Current
InterestReceivableCurrent
123000
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
241000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
92000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2668000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1419000
CY2023Q4 sepn Prepaid Taxes Current
PrepaidTaxesCurrent
75000
CY2024Q3 us-gaap Interest Receivable Current
InterestReceivableCurrent
123000
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
241000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
92000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2668000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1419000
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7953000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6287000
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2541000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1622000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5412000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4665000
CY2024Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
400000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1000000
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
200000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
600000
CY2024Q3 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
2109000
CY2023Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
2954000
CY2024Q3 sepn Accrued General And Administrative Expense Current
AccruedGeneralAndAdministrativeExpenseCurrent
1845000
CY2023Q4 sepn Accrued General And Administrative Expense Current
AccruedGeneralAndAdministrativeExpenseCurrent
209000
CY2024Q3 sepn Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
1699000
CY2023Q4 sepn Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
829000
CY2024Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
200000
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
200000
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
134000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
85000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5987000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4277000
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7953000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6287000
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2541000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1622000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5412000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4665000
CY2024Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
400000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1000000
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
200000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
600000
CY2024Q3 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
2109000
CY2023Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
2954000
CY2024Q3 sepn Accrued General And Administrative Expense Current
AccruedGeneralAndAdministrativeExpenseCurrent
1845000
CY2023Q4 sepn Accrued General And Administrative Expense Current
AccruedGeneralAndAdministrativeExpenseCurrent
209000
CY2024Q3 sepn Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
1699000
CY2023Q4 sepn Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
829000
CY2024Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
200000
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
200000
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
134000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
85000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5987000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4277000
CY2024Q3 sepn Cash And Cash Equivalents And Marketable Securities Fair Value Disclosure
CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure
132671000
CY2023Q4 sepn Cash And Cash Equivalents And Marketable Securities Fair Value Disclosure
CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure
86574000
CY2024Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
13
CY2024Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
64641000
CY2024Q3 sepn Available For Sale Securities Debt Maturities Within One Year Gross Unrealized Gains
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains
63000
CY2024Q3 sepn Available For Sale Securities Debt Maturities Within One Year Gross Unrealized Loss
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss
3000
CY2024Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
64701000
CY2024Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
71504000
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
179000
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
3000
CY2024Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
71680000
CY2024Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
22715000
CY2024Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
3000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
437000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
4469000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
4612000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
4760000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Four
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour
4912000
CY2024Q3 sepn Cash And Cash Equivalents And Marketable Securities Fair Value Disclosure
CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure
132671000
CY2023Q4 sepn Cash And Cash Equivalents And Marketable Securities Fair Value Disclosure
CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure
86574000
CY2024Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
13
CY2024Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
64641000
CY2024Q3 sepn Available For Sale Securities Debt Maturities Within One Year Gross Unrealized Gains
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains
63000
CY2024Q3 sepn Available For Sale Securities Debt Maturities Within One Year Gross Unrealized Loss
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLoss
3000
CY2024Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
64701000
CY2024Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
71504000
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
179000
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
3000
CY2024Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
71680000
CY2024Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
22715000
CY2024Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
3000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
437000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
4469000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
4612000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
4760000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Four
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour
4912000
CY2024Q3 sepn Lessee Operating Lease Liability To Be Paid After Rolling Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterRollingYearFour
18921000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
38111000
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
12885000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
25226000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1116000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
24110000
CY2024Q3 sepn Lessee Operating Lease Liability To Be Paid After Rolling Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterRollingYearFour
18921000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
38111000
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
12885000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1116000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
24110000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
25226000
CY2024Q3 sepn Liabilities Associated With Indemnification Rights And Agreements
LiabilitiesAssociatedWithIndemnificationRightsAndAgreements
0
CY2023Q4 sepn Liabilities Associated With Indemnification Rights And Agreements
LiabilitiesAssociatedWithIndemnificationRightsAndAgreements
0
CY2024Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
27443360
CY2023Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
26599602
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
300000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
900000
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
400000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
900000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.54
CY2024Q3 sepn Share Based Compensation Equity Awards Other Than Options Grants Fair Value
ShareBasedCompensationEquityAwardsOtherThanOptionsGrantsFairValue
10500000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.46
sepn Share Based Compensation Equity Awards Other Than Options Grants Fair Value
ShareBasedCompensationEquityAwardsOtherThanOptionsGrantsFairValue
12400000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
700000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
700000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
25226000
CY2024Q3 sepn Liabilities Associated With Indemnification Rights And Agreements
LiabilitiesAssociatedWithIndemnificationRightsAndAgreements
0
CY2023Q4 sepn Liabilities Associated With Indemnification Rights And Agreements
LiabilitiesAssociatedWithIndemnificationRightsAndAgreements
0
CY2024Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
27443360
CY2023Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
26599602
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
300000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
900000
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
400000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
900000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.54
CY2024Q3 sepn Share Based Compensation Equity Awards Other Than Options Grants Fair Value
ShareBasedCompensationEquityAwardsOtherThanOptionsGrantsFairValue
10500000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.46
sepn Share Based Compensation Equity Awards Other Than Options Grants Fair Value
ShareBasedCompensationEquityAwardsOtherThanOptionsGrantsFairValue
12400000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
700000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
700000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
683000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
347000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1888000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1045000
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
10200000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2986349
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
683000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
347000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1888000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1045000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2986349
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1170845
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1170845

Files In Submission

Name View Source Status
0000950170-24-129274-index-headers.html Edgar Link pending
0000950170-24-129274-index.html Edgar Link pending
0000950170-24-129274.txt Edgar Link pending
0000950170-24-129274-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img117579907_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sepn-20240930.htm Edgar Link pending
sepn-20240930.xsd Edgar Link pending
sepn-ex31_1.htm Edgar Link pending
sepn-ex31_2.htm Edgar Link pending
sepn-ex32_1.htm Edgar Link pending
Show.js Edgar Link pending
sepn-20240930_htm.xml Edgar Link completed